We read with great interest the article by Jung and coworkers on the validity of the seventh TNM classification of gastric cancer (GC). 1 The Authors concluded that it may be considered valid, but proposed a new hybrid TNM classification. In our opinion, several potential bias due to selection and classification criteria could have affected the results: 1) In the seventh TNM, carcinomas with the epicenter located within 5 cm of the esophagogastric junction (EGJ) and also extending to the esophagus are considered and staged as esophageal cancer; then, they should be excluded from GC series. According to the reported methods, this selection was not performed. The different staging system and prognosis of EGJ carcinomas could have affected the results of the study. 2) Although the new TNM recommends a minimum number of 15 lymph nodes to be analyzed, this is not an exclusion criteria for TNM classification. Indeed, the new staging system need to be applied even when fewer lymph nodes are removed, as it occurs in a large proportion of GC patients in the world. 2 Being the interaction between the number of analyzed nodes and pN status 1 of the main problems of staging systems, the new TNM requires validation in this setting. 3) Residual tumor (R) classification, although being an important prognostic factor for GC, is not part of the TNM stage. It is unclear why the authors decided to exclude R1/R2 cases from their analysis. Survival probabilities may have been overestimated, particularly in advanced stages. 4) In the new TNM, cases with positive peritoneal cytology (cyþ) are now considered as M1, and included in stage IV. As such, it is not correct that ''stage IV disease is only defined for patients with a definitive distant metastasis''. Furthermore, no information about peritoneal cytology is provided by the Authors. In our opinion, potential stage migration and prognostic uniformity between cyþM0 and M1 cases in stage IV of the seventh TNM need to be clinically validated.In conclusion, proper selection and classification criteria should be used in the evaluation of the new TNM staging system for GC. We believe that, until these criteria are applied, any estimation of its validity or proposals of new staging systems remain aleatory.